Wet extrusion of fibronectin-fibrinogen cables for application in tissue engineering

A method for the wet extrusion of human plasma‐derived fibronectin–fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without sodium alginate and carboxymethylcellulose (CMC) are tested. The rheological properties of the protein solutions changed from Newtonian to shear...

Full description

Saved in:
Bibliographic Details
Published inBiotechnology and bioengineering Vol. 73; no. 4; pp. 295 - 305
Main Authors Underwood, S., Afoke, A., Brown, R. A., MacLeod, A. J., Shamlou, P. Ayazi, Dunnill, P.
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 20.05.2001
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A method for the wet extrusion of human plasma‐derived fibronectin–fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without sodium alginate and carboxymethylcellulose (CMC) are tested. The rheological properties of the protein solutions changed from Newtonian to shear thinning non‐Newtonian in the presence of small quantities of these additives, the apparent viscosity increased, and the extrusion properties of the protein solutions improved. Cables were prepared using a capillary with a diameter of 1 mm and overall length of 18 mm. Cable diameter was reduced to about 0.5 mm by drawing using a series of rollers. Cables prepared with sodium alginate were found to have suitable properties, and those made with CMC were sticky and difficult to handle. Solutions containing no sodium alginate required a minimum total protein concentration of about 70 mg/mL for extrusion. Extruded cables were prepared with solutions containing 140 mg/mL total protein with 12.9 mg/mL alginate (high protein), and 46 mg/mL total protein with 47.6 mg/mL of sodium alginate (high alginate). The mechanical strength of the extruded cables was within the range suitable for application in tissue engineering. Extrusion of the protein solutions into cables was achieved in a coagulation bath. Cables with a mechanical strength of approximately 30 N/mm2, suitable for wound repair and nerve regeneration applications, were prepared with a coagulation bath containing 0.25 M HCl, 2% CaCl2 at a pH of <0.9. These cables also had a large average elongation at break of 52%, and showed an increase in cable length after breakage (permanent set) of 20%, demonstrating the potential for drawing the cables down to a fine diameter. © 2001 John Wiley & Sons, Inc. Biotechnol Bioeng 73: 295–305, 2001.
AbstractList A method for the wet extrusion of human plasma-derived fibronectin-fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without sodium alginate and carboxymethylcellulose (CMC) are tested. The rheological properties of the protein solutions changed from Newtonian to shear thinning non-Newtonian in the presence of small quantities of these additives, the apparent viscosity increased, and the extrusion properties of the protein solutions improved. Cables were prepared using a capillary with a diameter of 1 mm and overall length of 18 mm. Cable diameter was reduced to about 0.5 mm by drawing using a series of rollers. Cables prepared with sodium alginate were found to have suitable properties, and those made with CMC were sticky and difficult to handle. Solutions containing no sodium alginate required a minimum total protein concentration of about 70 mg/mL for extrusion. Extruded cables were prepared with solutions containing 140 mg/mL total protein with 12.9 mg/mL alginate (high protein), and 46 mg/mL total protein with 47.6 mg/mL of sodium alginate (high alginate). The mechanical strength of the extruded cables was within the range suitable for application in tissue engineering. Extrusion of the protein solutions into cables was achieved in a coagulation bath. Cables with a mechanical strength of approximately 30 N/mm super(2), suitable for wound repair and nerve regeneration applications, were prepared with a coagulation bath containing 0.25 M HCl, 2% CaCl sub(2) at a pH of <0.9. These cables also had a large average elongation at break of 52%, and showed an increase in cable length after breakage (permanent set) of 20%, demonstrating the potential for drawing the cables down to a fine diameter.
Abstract A method for the wet extrusion of human plasma‐derived fibronectin–fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without sodium alginate and carboxymethylcellulose (CMC) are tested. The rheological properties of the protein solutions changed from Newtonian to shear thinning non‐Newtonian in the presence of small quantities of these additives, the apparent viscosity increased, and the extrusion properties of the protein solutions improved. Cables were prepared using a capillary with a diameter of 1 mm and overall length of 18 mm. Cable diameter was reduced to about 0.5 mm by drawing using a series of rollers. Cables prepared with sodium alginate were found to have suitable properties, and those made with CMC were sticky and difficult to handle. Solutions containing no sodium alginate required a minimum total protein concentration of about 70 mg/mL for extrusion. Extruded cables were prepared with solutions containing 140 mg/mL total protein with 12.9 mg/mL alginate (high protein), and 46 mg/mL total protein with 47.6 mg/mL of sodium alginate (high alginate). The mechanical strength of the extruded cables was within the range suitable for application in tissue engineering. Extrusion of the protein solutions into cables was achieved in a coagulation bath. Cables with a mechanical strength of approximately 30 N/mm 2 , suitable for wound repair and nerve regeneration applications, were prepared with a coagulation bath containing 0.25 M HCl, 2% CaCl 2 at a pH of <0.9. These cables also had a large average elongation at break of 52%, and showed an increase in cable length after breakage (permanent set) of 20%, demonstrating the potential for drawing the cables down to a fine diameter. © 2001 John Wiley & Sons, Inc. Biotechnol Bioeng 73: 295–305, 2001.
A method for the wet extrusion of human plasma-derived fibronectin-fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without sodium alginate and carboxymethylcellulose (CMC) are tested. The rheological properties of the protein solutions changed from Newtonian to shear thinning non-Newtonian in the presence of small quantities of these additives, the apparent viscosity increased, and the extrusion properties of the protein solutions improved. Cables were prepared using a capillary with a diameter of 1 mm and overall length of 18 mm. Cable diameter was reduced to about 0.5 mm by drawing using a series of rollers. Cables prepared with sodium alginate were found to have suitable properties, and those made with CMC were sticky and difficult to handle. Solutions containing no sodium alginate required a minimum total protein concentration of about 70 mg/mL for extrusion. Extruded cables were prepared with solutions containing 140 mg/mL total protein with 12.9 mg/mL alginate (high protein), and 46 mg/mL total protein with 47.6 mg/mL of sodium alginate (high alginate). The mechanical strength of the extruded cables was within the range suitable for application in tissue engineering. Extrusion of the protein solutions into cables was achieved in a coagulation bath. Cables with a mechanical strength of approximately 30 N/mm(2), suitable for wound repair and nerve regeneration applications, were prepared with a coagulation bath containing 0.25 M HCl, 2% CaCl(2) at a pH of &lt;0.9. These cables also had a large average elongation at break of 52%, and showed an increase in cable length after breakage (permanent set) of 20%, demonstrating the potential for drawing the cables down to a fine diameter.
A method for the wet extrusion of human plasma‐derived fibronectin–fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without sodium alginate and carboxymethylcellulose (CMC) are tested. The rheological properties of the protein solutions changed from Newtonian to shear thinning non‐Newtonian in the presence of small quantities of these additives, the apparent viscosity increased, and the extrusion properties of the protein solutions improved. Cables were prepared using a capillary with a diameter of 1 mm and overall length of 18 mm. Cable diameter was reduced to about 0.5 mm by drawing using a series of rollers. Cables prepared with sodium alginate were found to have suitable properties, and those made with CMC were sticky and difficult to handle. Solutions containing no sodium alginate required a minimum total protein concentration of about 70 mg/mL for extrusion. Extruded cables were prepared with solutions containing 140 mg/mL total protein with 12.9 mg/mL alginate (high protein), and 46 mg/mL total protein with 47.6 mg/mL of sodium alginate (high alginate). The mechanical strength of the extruded cables was within the range suitable for application in tissue engineering. Extrusion of the protein solutions into cables was achieved in a coagulation bath. Cables with a mechanical strength of approximately 30 N/mm2, suitable for wound repair and nerve regeneration applications, were prepared with a coagulation bath containing 0.25 M HCl, 2% CaCl2 at a pH of <0.9. These cables also had a large average elongation at break of 52%, and showed an increase in cable length after breakage (permanent set) of 20%, demonstrating the potential for drawing the cables down to a fine diameter. © 2001 John Wiley & Sons, Inc. Biotechnol Bioeng 73: 295–305, 2001.
A method for the wet extrusion of human plasma-derived fibronectin-fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without sodium alginate and carboxymethylcellulose (CMC) are tested. The rheological properties of the protein solutions changed from Newtonian to shear thinning non-Newtonian in the presence of small quantities of these additives, the apparent viscosity increased, and the extrusion properties of the protein solutions improved. Cables were prepared using a capillary with a diameter of 1 mm and overall length of 18 mm. Cable diameter was reduced to about 0.5 mm by drawing using a series of rollers. Cables prepared with sodium alginate were found to have suitable properties, and those made with CMC were sticky and difficult to handle. Solutions containing no sodium alginate required a minimum total protein concentration of about 70 mg/mL for extrusion. Extruded cables were prepared with solutions containing 140 mg/mL total protein with 12.9 mg/mL alginate (high protein), and 46 mg/mL total protein with 47.6 mg/mL of sodium alginate (high alginate). The mechanical strength of the extruded cables was within the range suitable for application in tissue engineering. Extrusion of the protein solutions into cables was achieved in a coagulation bath. Cables with a mechanical strength of approximately 30 N/mm(2), suitable for wound repair and nerve regeneration applications, were prepared with a coagulation bath containing 0.25 M HCl, 2% CaCl(2) at a pH of <0.9. These cables also had a large average elongation at break of 52%, and showed an increase in cable length after breakage (permanent set) of 20%, demonstrating the potential for drawing the cables down to a fine diameter.
Author Shamlou, P. Ayazi
Underwood, S.
Afoke, A.
MacLeod, A. J.
Dunnill, P.
Brown, R. A.
Author_xml – sequence: 1
  givenname: S.
  surname: Underwood
  fullname: Underwood, S.
  organization: Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, Torrington Place, University College London, London WC1E 7JE, UK; telephone: 0207-380-7031; fax: 0207-209-0703
– sequence: 2
  givenname: A.
  surname: Afoke
  fullname: Afoke, A.
  organization: Department of Technology and Design, University of Westminster, London, UK
– sequence: 3
  givenname: R. A.
  surname: Brown
  fullname: Brown, R. A.
  organization: Tissue Repair Unit, Department of Plastic Surgery, University College London, London, UK
– sequence: 4
  givenname: A. J.
  surname: MacLeod
  fullname: MacLeod, A. J.
  organization: Protein Fractionation Centre, Scottish National Blood Transfusion Service, Edinburgh, UK
– sequence: 5
  givenname: P. Ayazi
  surname: Shamlou
  fullname: Shamlou, P. Ayazi
  organization: Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, Torrington Place, University College London, London WC1E 7JE, UK; telephone: 0207-380-7031; fax: 0207-209-0703
– sequence: 6
  givenname: P.
  surname: Dunnill
  fullname: Dunnill, P.
  email: p.dunnill@ucl.ac.uk
  organization: Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, Torrington Place, University College London, London WC1E 7JE, UK; telephone: 0207-380-7031; fax: 0207-209-0703
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1056661$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11283912$$D View this record in MEDLINE/PubMed
BookMark eNqF0EFrFDEUB_AgFbutQj9BmYOIl9GXzCSZHLVoW1iU0tVCLyGTfVnSzma2yQy2394MO2gv4ikv8Mv_kf8ROQh9QEJOKHygAOxj64c8CPaCLCgoWQJTcEAWACDKiit2SI5SustX2QjxihxSyppKUbYgqxscCnwc4ph8H4reFc63MafbwYdymn3oNxgKa9oOU-H6WJjdrvPWDNMDH4rBpzRigWHjA2L2m9fkpTNdwjfzeUx-fP2yOrsol9_PL88-LUtbU85KrGvrGsEYk5SDgRYrjmtplXNSCcpUzRteS2bXyJHWoNbOCtkguKq1XNLqmLzb5-5i_zBiGvTWJ4tdZwL2Y9JSAgVO6_9C2lR5F4MM3--hjX1KEZ3eRb818UlT0FPVOletp6ozPZ0zx3aL679w7jaDtzMwyZrORROsT88CuRBi-kS5Z798h0__3Kc_X67mvbP3acDHP97Eey1kJbm--Xauf4qLW7FU1_qq-g2Fh6Uf
CODEN BIBIAU
CitedBy_id crossref_primary_10_1088_1748_6041_2_4_008
crossref_primary_10_3390_ma10060568
crossref_primary_10_1097_01_prs_0000299373_25294_65
crossref_primary_10_1039_D0RA10749B
crossref_primary_10_1021_acsnano_7b07196
crossref_primary_10_1002_jbm_a_32572
crossref_primary_10_1155_2021_4907027
crossref_primary_10_1179_174328905X55632
crossref_primary_10_1186_s11671_018_2491_8
crossref_primary_10_1016_j_actbio_2005_09_008
crossref_primary_10_1002_term_284
crossref_primary_10_1016_j_biomaterials_2003_09_052
crossref_primary_10_1089_ten_tea_2008_0603
crossref_primary_10_1016_j_biotechadv_2010_01_004
crossref_primary_10_3389_fmolb_2021_783268
crossref_primary_10_1016_j_colsurfb_2013_07_016
crossref_primary_10_3390_molecules26030619
crossref_primary_10_1021_acs_biomac_8b01258
crossref_primary_10_1016_j_expneurol_2018_05_016
crossref_primary_10_1002_jbm_a_30989
crossref_primary_10_1002_sstr_202000137
crossref_primary_10_1179_1743280414Y_0000000049
crossref_primary_10_5115_acb_21_233
crossref_primary_10_1177_155892500800300204
crossref_primary_10_1016_S0009_2509_01_00392_X
crossref_primary_10_1089_107632703764664693
Cites_doi 10.1126/science.8493529
10.1016/S0007-1226(97)91325-4
10.1046/j.1469-7580.1998.19320273.x
10.1126/science.7008197
10.1038/385537a0
10.1016/S0142-9612(98)00015-5
10.1016/S0065-3233(08)60588-4
10.1002/bip.360261208
10.1111/j.1460-9568.1995.tb00643.x
10.1083/jcb.139.3.709
10.1016/0142-9612(94)90225-9
10.1007/s11626-997-0031-4
10.1038/nbt0695-565
10.1515/bchm2.1983.364.1.551
10.1016/0142-9612(93)90038-4
10.1002/jbm.820140203
10.1046/j.1524-475X.1997.50304.x
10.1016/S0266-7681(05)80148-2
10.1021/ja00076a077
10.1016/0005-2795(75)90294-9
10.1111/j.1460-9568.1997.tb01493.x
10.1002/(SICI)1097-0169(1999)42:4<331::AID-CM6>3.0.CO;2-7
10.1002/(SICI)1097-0169(200005)46:1<6::AID-CM2>3.0.CO;2-Z
10.1089/ten.1995.1.151
10.1016/S0266-7681(96)80058-1
10.1002/bip.360340808
10.1182/blood.V56.2.145.145
10.1007/s004490050586
ContentType Journal Article
Copyright Copyright © 2001 John Wiley & Sons, Inc.
2001 INIST-CNRS
Copyright 2001 John Wiley & Sons, Inc.
Copyright_xml – notice: Copyright © 2001 John Wiley & Sons, Inc.
– notice: 2001 INIST-CNRS
– notice: Copyright 2001 John Wiley & Sons, Inc.
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
8FD
FR3
P64
7X8
DOI 10.1002/bit.1062
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Engineering Research Database
CrossRef
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Chemistry
Biology
Anatomy & Physiology
EISSN 1097-0290
EndPage 305
ExternalDocumentID 10_1002_bit_1062
11283912
1056661
BIT1062
ark_67375_WNG_V6HZ6L9S_Q
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Biotechnology and Biological Sciences Research Council
– fundername: PFC Edinburgh
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23N
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAJUZ
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABCVL
ABHUG
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACIWK
ACPOU
ACPRK
ACSMX
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFVGU
AFZJQ
AGJLS
AHBTC
AI.
AIAGR
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BLYAC
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBS
EJD
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
P2P
P2W
P2X
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RBB
RNS
ROL
RWI
RX1
SUPJJ
TN5
UB1
V2E
VH1
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WNSPC
WOHZO
WQJ
WRC
WXSBR
WYISQ
XFK
XG1
XPP
XSW
XV2
Y6R
ZZTAW
~02
~IA
~KM
~WT
AITYG
HGLYW
OIG
08R
3EH
AAPBV
ABEML
ACSCC
EBD
EMOBN
HF~
IQODW
LH6
NDZJH
PALCI
RIWAO
RJQFR
RYL
SAMSI
SV3
WSB
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
8FD
FR3
P64
7X8
ID FETCH-LOGICAL-c4152-e44cf862227150a0be35ed7c9ff7961294585472cde5e1409dfc678e0f3bc5713
IEDL.DBID DR2
ISSN 0006-3592
IngestDate Fri Aug 16 10:48:47 EDT 2024
Sat Aug 17 02:29:48 EDT 2024
Fri Aug 23 00:44:11 EDT 2024
Sat Sep 28 07:36:20 EDT 2024
Sun Oct 22 16:07:05 EDT 2023
Sat Aug 24 00:53:59 EDT 2024
Wed Jan 17 04:59:22 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Tissue engineering
Medical application
Fibronectin
Wet spinning
Composite material
Fibrinogen
Language English
License CC BY 4.0
Copyright 2001 John Wiley & Sons, Inc.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4152-e44cf862227150a0be35ed7c9ff7961294585472cde5e1409dfc678e0f3bc5713
Notes istex:AC1702A38A6D422BC8E3D4367A671BF49EF26CAD
ark:/67375/WNG-V6HZ6L9S-Q
PFC Edinburgh
Biotechnology and Biological Sciences Research Council
ArticleID:BIT1062
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 11283912
PQID 18345820
PQPubID 23462
PageCount 11
ParticipantIDs proquest_miscellaneous_77010514
proquest_miscellaneous_18345820
crossref_primary_10_1002_bit_1062
pubmed_primary_11283912
pascalfrancis_primary_1056661
wiley_primary_10_1002_bit_1062_BIT1062
istex_primary_ark_67375_WNG_V6HZ6L9S_Q
PublicationCentury 2000
PublicationDate 20 May 2001
PublicationDateYYYYMMDD 2001-05-20
PublicationDate_xml – month: 05
  year: 2001
  text: 20 May 2001
  day: 20
PublicationDecade 2000
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: New York, NY
– name: United States
PublicationTitle Biotechnology and bioengineering
PublicationTitleAlternate Biotechnol. Bioeng
PublicationYear 2001
Publisher John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley
References Ahmed Z, Idowu BD, Brown RA. 1999. Stabilisation of fibronectin mats with micromolar concentrations of copper. Biomaterials 20:201-210.
Mosesson MW, Amrani DL. 1980. The structure and biologic activities of plasma fibronectin. Blood 56:145-158.
Palecek SP, Loftus JC, Ginsberg MH, Lauffenburger DA, Horwitz AF. 1997. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 385:537-540.
Brown RA, Blunn GW, Ejim OS. 1994. Preparation of orientated fibrous mats from fibronectin: composition and stability. Biomaterials 15:457-464.
Homandberg GA. 1987. Characterization of the interactions of an amino-terminal fibronectin fragment with the native molecule: implications for polymerization of fibronectin. Biopolymers 26:2087-2098.
Mosesson MW, Chen AB, Huseby RM. 1975. The cold-insoluble globulin of human plasma: studies of the essential structural features. Biochim Biophys Acta 386:509-524.
Hobson MI, Brown R, Green CJ, Terenghi G. 1997. Inter-relationships between angiogenesis and nerve regeneration: a histochemical study. Br Plast Surg 50:125-131.
Wojciak-Stothard B, Denyer M, Mishra M, Brown RA. 1997. Adhesion, orientation and movement of cells cultured on ultrathin fibronectin fibres. In Vitro Cell Dev Biol Anim 33:110-117.
Sterne GD, Brown RA, Green CJ, Terenghi G. 1997a. Neurotrophin-3 delivered locally via fibronectin mats enhances peripheral nerve regeneration. Eur J Neurosci 9:1388-1396.
Whitworth IH, Terenghi G, Green CJ, Brown RA, Stevens E, Tomlinson DR. 1995b. Targeted delivery of nerve growth factor via fibronectin conduits assists nerve regeneration in control and diabetic rats. Eur J Neurosci 7:2220-2225.
Markovic Z, Engel J, Richter H, Hormann H. 1983. Determination of different domains in fibronectin on the basis of their stability against urea denaturation. Hoppe Seyler Physiol Z 364:551-561.
Brown RA, Smith KD, McGrouther A. 1997. Strategies for cell engineering in tissue repair. Wound Rep Reg 5:212-221.
Sterne GD, Brown RA, Green CJ, Terenghi G. 1998. NT-3 modulates NPY expression in primary sensory neurons following peripheral nerve injury. J Anat 193:273-281.
Hubbell JA. 1995. Biomaterials in tissue engineering. Bio/Technology 13:565-576.
Yannas IV, Burke JF, Gordon PL, Huang C, Rubenstein RH. 1980. Design of an artificial skin. II. Control of chemical composition. J Biomed Mater Res 14:107-131.
Lundgren HP. 1949. Synthetic fibres made from proteins. Adv Prot Chem 5:305-351.
Ahmed Z, Underwood S, Brown RA. 2000. Low concentrations of fibrinogen increase cell migration speed on fibronectin/fibrinogen composite cables. Cell Motil Cytoskel 46:6-16.
Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T. 1981. Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211:1052-1054.
Langer R, Vacanti JP, Vacanti CA, Atala A, Freed LE, Vunjak-Novakovic G. 1995. Tissue engineering: biomedical applications. Tissue Eng 1:151-161.
Underwood S, Afoke A, Brown RA, MacLeod AJ, Dunnill P. 1999. The physical properties of a fibrillar fibronectin-fibrinogen material with potential use in tissue engineering. Bioproc Eng 20:239-248.
Whitworth IH, Brown RA, Dore C, Green CJ, Terenghi G. 1995a. Orientated mats of fibronectin as a conduit material for use in peripheral nerve regeneration. J Hand Surg 20B:429-435.
Sterne GD, Coulton GR, Brown RA, Green CJ, Terenghi G. 1997b. Neurotrophin-3-enhanced nerve regeneration selectively improves recovery of muscle fibres expressing myosin heavy chains 2b. J Cell Biol 139:709-715.
Anderson JP, Cappello J, Martin DC. 1994. Morphology and primary crystal structure of a silk-like protein polymer synthesized by genetically engineered Escherichia coli bacteria. Biopolymers 34:1049-1058.
Whitworth IH, Brown RA, Dore CJ, Anand P, Green CJ, Terenghi G. 1996. Nerve growth factor enhances nerve regeneration through fibronectin grafts. J Hand Surg 21B:514-522.
Barrera DA, Zylstra E, Lansbury PT, Langer R. 1993. Synthesis and RGD modification of a new biodegradable copolymer: poly (lactic acid-co-lysine). J Am Chem Soc 115:11010-11011.
Berger SA, Goldsmith W, Lewis ER. 1996. Introduction to bioengineering. Oxford: Oxford University Press.
Langer R, Vacanti JP. 1993. Tissue engineering. Science 260:920-925.
Ejim OS, Blunn GW, Brown RA. 1993. Production of artificial-orientated mats and strands from plasma fibronectin: a morphological study. Biomaterials 14:743-748.
Ahmed Z, Brown RA. 1999. Adhesion, alignment, and migration of cultured Schwann cells on ultrathin fibronectin fibres. Cell Motil Cytoskel 42:331-343.
2000; 46
1995; 13
1997a; 9
1995b; 7
1949; 5
1995a; 20B
1993; 260
1996
1999; 42
1999; 20
1975; II
1997; 5
1995; 1
1993; 14
1998; 193
1980; 14
1997; 50
1983; 364
1997; 33
1981; 211
1996; 21B
1980; 56
1997; 385
1994; 34
1975; 386
1994; 15
1997b; 139
1993; 115
1987; 26
1989
Doolittle RF (e_1_2_1_11_1) 1975
Mosesson MW (e_1_2_1_20_1) 1980; 56
e_1_2_1_23_1
e_1_2_1_24_1
e_1_2_1_21_1
e_1_2_1_22_1
e_1_2_1_27_1
e_1_2_1_28_1
e_1_2_1_25_1
e_1_2_1_26_1
e_1_2_1_29_1
e_1_2_1_7_1
e_1_2_1_30_1
e_1_2_1_5_1
e_1_2_1_6_1
Yamada K (e_1_2_1_31_1) 1989
e_1_2_1_3_1
e_1_2_1_12_1
e_1_2_1_4_1
e_1_2_1_13_1
e_1_2_1_10_1
e_1_2_1_2_1
e_1_2_1_32_1
e_1_2_1_16_1
e_1_2_1_17_1
e_1_2_1_14_1
e_1_2_1_15_1
Berger SA (e_1_2_1_8_1) 1996
e_1_2_1_9_1
e_1_2_1_18_1
e_1_2_1_19_1
References_xml – volume: 34
  start-page: 1049
  year: 1994
  end-page: 1058
  article-title: Morphology and primary crystal structure of a silk‐like protein polymer synthesized by genetically engineered bacteria
  publication-title: Biopolymers
– volume: 139
  start-page: 709
  year: 1997b
  end-page: 715
  article-title: Neurotrophin‐3‐enhanced nerve regeneration selectively improves recovery of muscle fibres expressing myosin heavy chains 2b
  publication-title: J Cell Biol
– volume: 14
  start-page: 107
  year: 1980
  end-page: 131
  article-title: Design of an artificial skin. II. Control of chemical composition
  publication-title: J Biomed Mater Res
– volume: 33
  start-page: 110
  year: 1997
  end-page: 117
  article-title: Adhesion, orientation and movement of cells cultured on ultrathin fibronectin fibres
  publication-title: In Vitro Cell Dev Biol Anim
– volume: 46
  start-page: 6
  year: 2000
  end-page: 16
  article-title: Low concentrations of fibrinogen increase cell migration speed on fibronectin/fibrinogen composite cables
  publication-title: Cell Motil Cytoskel
– volume: 386
  start-page: 509
  year: 1975
  end-page: 524
  article-title: The cold‐insoluble globulin of human plasma: studies of the essential structural features
  publication-title: Biochim Biophys Acta
– volume: 14
  start-page: 743
  year: 1993
  end-page: 748
  article-title: Production of artificial‐orientated mats and strands from plasma fibronectin: a morphological study
  publication-title: Biomaterials
– volume: 211
  start-page: 1052
  year: 1981
  end-page: 1054
  article-title: Living tissue formed in vitro and accepted as skin‐equivalent tissue of full thickness
  publication-title: Science
– year: 1996
– volume: 1
  start-page: 151
  year: 1995
  end-page: 161
  article-title: Tissue engineering: biomedical applications
  publication-title: Tissue Eng
– volume: 115
  start-page: 11010
  year: 1993
  end-page: 11011
  article-title: Synthesis and RGD modification of a new biodegradable copolymer: poly (lactic acid‐co‐lysine)
  publication-title: J Am Chem Soc
– volume: 20B
  start-page: 429
  year: 1995a
  end-page: 435
  article-title: Orientated mats of fibronectin as a conduit material for use in peripheral nerve regeneration
  publication-title: J Hand Surg
– volume: II
  start-page: 110
  year: 1975
  end-page: 161
– volume: 5
  start-page: 212
  year: 1997
  end-page: 221
  article-title: Strategies for cell engineering in tissue repair
  publication-title: Wound Rep Reg
– volume: 5
  start-page: 305
  year: 1949
  end-page: 351
  article-title: Synthetic fibres made from proteins
  publication-title: Adv Prot Chem
– start-page: 51
  year: 1989
  end-page: 68
– volume: 50
  start-page: 125
  year: 1997
  end-page: 131
  article-title: Inter‐relationships between angiogenesis and nerve regeneration: a histochemical study
  publication-title: Br Plast Surg
– volume: 13
  start-page: 565
  year: 1995
  end-page: 576
  article-title: Biomaterials in tissue engineering
  publication-title: Bio/Technology
– volume: 56
  start-page: 145
  year: 1980
  end-page: 158
  article-title: The structure and biologic activities of plasma fibronectin
  publication-title: Blood
– volume: 260
  start-page: 920
  year: 1993
  end-page: 925
  article-title: Tissue engineering
  publication-title: Science
– volume: 364
  start-page: 551
  year: 1983
  end-page: 561
  article-title: Determination of different domains in fibronectin on the basis of their stability against urea denaturation
  publication-title: Hoppe Seyler Physiol Z
– volume: 385
  start-page: 537
  year: 1997
  end-page: 540
  article-title: Integrin–ligand binding properties govern cell migration speed through cell‐substratum adhesiveness
  publication-title: Nature
– volume: 20
  start-page: 239
  year: 1999
  end-page: 248
  article-title: The physical properties of a fibrillar fibronectin–fibrinogen material with potential use in tissue engineering
  publication-title: Bioproc Eng
– volume: 21B
  start-page: 514
  year: 1996
  end-page: 522
  article-title: Nerve growth factor enhances nerve regeneration through fibronectin grafts
  publication-title: J Hand Surg
– volume: 7
  start-page: 2220
  year: 1995b
  end-page: 2225
  article-title: Targeted delivery of nerve growth factor via fibronectin conduits assists nerve regeneration in control and diabetic rats
  publication-title: Eur J Neurosci
– volume: 15
  start-page: 457
  year: 1994
  end-page: 464
  article-title: Preparation of orientated fibrous mats from fibronectin: composition and stability
  publication-title: Biomaterials
– volume: 26
  start-page: 2087
  year: 1987
  end-page: 2098
  article-title: Characterization of the interactions of an amino‐terminal fibronectin fragment with the native molecule: implications for polymerization of fibronectin
  publication-title: Biopolymers
– volume: 20
  start-page: 201
  year: 1999
  end-page: 210
  article-title: Stabilisation of fibronectin mats with micromolar concentrations of copper
  publication-title: Biomaterials
– volume: 9
  start-page: 1388
  year: 1997a
  end-page: 1396
  article-title: Neurotrophin‐3 delivered locally via fibronectin mats enhances peripheral nerve regeneration
  publication-title: Eur J Neurosci
– volume: 42
  start-page: 331
  year: 1999
  end-page: 343
  article-title: Adhesion, alignment, and migration of cultured Schwann cells on ultrathin fibronectin fibres
  publication-title: Cell Motil Cytoskel
– volume: 193
  start-page: 273
  year: 1998
  end-page: 281
  article-title: NT‐3 modulates NPY expression in primary sensory neurons following peripheral nerve injury
  publication-title: J Anat
– ident: e_1_2_1_16_1
  doi: 10.1126/science.8493529
– ident: e_1_2_1_13_1
  doi: 10.1016/S0007-1226(97)91325-4
– ident: e_1_2_1_24_1
  doi: 10.1046/j.1469-7580.1998.19320273.x
– ident: e_1_2_1_7_1
  doi: 10.1126/science.7008197
– volume-title: Introduction to bioengineering
  year: 1996
  ident: e_1_2_1_8_1
  contributor:
    fullname: Berger SA
– ident: e_1_2_1_22_1
  doi: 10.1038/385537a0
– ident: e_1_2_1_3_1
  doi: 10.1016/S0142-9612(98)00015-5
– ident: e_1_2_1_18_1
  doi: 10.1016/S0065-3233(08)60588-4
– start-page: 110
  year: 1975
  ident: e_1_2_1_11_1
  contributor:
    fullname: Doolittle RF
– ident: e_1_2_1_14_1
  doi: 10.1002/bip.360261208
– ident: e_1_2_1_29_1
  doi: 10.1111/j.1460-9568.1995.tb00643.x
– ident: e_1_2_1_25_1
  doi: 10.1083/jcb.139.3.709
– ident: e_1_2_1_9_1
  doi: 10.1016/0142-9612(94)90225-9
– ident: e_1_2_1_30_1
  doi: 10.1007/s11626-997-0031-4
– ident: e_1_2_1_15_1
  doi: 10.1038/nbt0695-565
– ident: e_1_2_1_19_1
  doi: 10.1515/bchm2.1983.364.1.551
– ident: e_1_2_1_12_1
  doi: 10.1016/0142-9612(93)90038-4
– ident: e_1_2_1_32_1
  doi: 10.1002/jbm.820140203
– ident: e_1_2_1_10_1
  doi: 10.1046/j.1524-475X.1997.50304.x
– ident: e_1_2_1_28_1
  doi: 10.1016/S0266-7681(05)80148-2
– ident: e_1_2_1_6_1
  doi: 10.1021/ja00076a077
– ident: e_1_2_1_21_1
  doi: 10.1016/0005-2795(75)90294-9
– ident: e_1_2_1_23_1
  doi: 10.1111/j.1460-9568.1997.tb01493.x
– ident: e_1_2_1_2_1
  doi: 10.1002/(SICI)1097-0169(1999)42:4<331::AID-CM6>3.0.CO;2-7
– ident: e_1_2_1_4_1
  doi: 10.1002/(SICI)1097-0169(200005)46:1<6::AID-CM2>3.0.CO;2-Z
– ident: e_1_2_1_17_1
  doi: 10.1089/ten.1995.1.151
– start-page: 51
  volume-title: Fibronectin
  year: 1989
  ident: e_1_2_1_31_1
  contributor:
    fullname: Yamada K
– ident: e_1_2_1_27_1
  doi: 10.1016/S0266-7681(96)80058-1
– ident: e_1_2_1_5_1
  doi: 10.1002/bip.360340808
– volume: 56
  start-page: 145
  year: 1980
  ident: e_1_2_1_20_1
  article-title: The structure and biologic activities of plasma fibronectin
  publication-title: Blood
  doi: 10.1182/blood.V56.2.145.145
  contributor:
    fullname: Mosesson MW
– ident: e_1_2_1_26_1
  doi: 10.1007/s004490050586
SSID ssj0007866
Score 1.8728942
Snippet A method for the wet extrusion of human plasma‐derived fibronectin–fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without...
A method for the wet extrusion of human plasma-derived fibronectin-fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and without...
Abstract A method for the wet extrusion of human plasma‐derived fibronectin–fibrinogen cables is described. Solutions of fibronectin and fibrinogen with and...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
istex
SourceType Aggregation Database
Index Database
Publisher
StartPage 295
SubjectTerms Alginates - chemistry
Biological and medical sciences
Biomedical Engineering
Biotechnology
Carboxymethylcellulose Sodium - chemistry
Coagulants - chemistry
Culture Techniques
Extracellular Matrix - chemistry
fibrinogen
Fibrinogen - chemistry
Fibrinogen - ultrastructure
fibronectin
Fibronectins - chemistry
Fibronectins - ultrastructure
Fundamental and applied biological sciences. Psychology
Glucuronic Acid
Health. Pharmaceutical industry
Hexuronic Acids
Humans
Industrial applications and implications. Economical aspects
Microscopy, Electron, Scanning
Miscellaneous
protein fibers
Rheology
tissue engineering
wet spinning
Title Wet extrusion of fibronectin-fibrinogen cables for application in tissue engineering
URI https://api.istex.fr/ark:/67375/WNG-V6HZ6L9S-Q/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbit.1062
https://www.ncbi.nlm.nih.gov/pubmed/11283912
https://search.proquest.com/docview/18345820
https://search.proquest.com/docview/77010514
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB-kRbQPVa9-rFqNIH3bdj-SzeWxLdZTpKD2C30I2WwCR-me9O5AffJ_8D_0L3Emue3diQXxaXdhNiSTyeQ3yeQXgJfWllLlpp867lXKvStS1ZR5WjjTr3xujLCB7fOwGhzzt2fibJZVSWdhIj_E1YIbjYzgr2mAm3q8MycNrYfE_hzcL_HoER76MGeOkv24TUkBcylU0fHOZsVO9-PSTLRKSv1KmZFmjMrx8VaLv8HOZRQbpqGDO_C5a0DMPjnfnk7qbfv9D27H_2vhXVifoVO2G83pHtxwbQ82dluMzC--sS0W8kXDQnwPbu51b7f2u1vjerC2QHC4ASenbsLQ_V9OaVGOjTzzWKNRS162_fXjJ30N2xEaMbN0hmvMEEOzhU11NmzZJNgGc_OC78Pxwauj_UE6u8khtQQQ0BC49Rg7FYVEAGqy2pXCNdLSgrFCjKU4Ri1cFrZxwhEFV-MtzqIu82VtBcbRD2Clxco9AmYb6epM9a3CeFo03nCO0k1eEZFhnWcJvOh6VX-JhB06UjMXGhWqSaEJbIXuvhIwl-eU4CaFPj18rU-qwafqnfqo3yewuWQPCyUiDK7yBJ539qFRz7TXYlo3mo41ekrakcyul5CSLifNeQIPo2HNC0fMUKqcqhnM49p26L03R_R8_K-CT-B2zKET6B2fwgp2v9tEUDWpn4Xh8xvTBR6i
link.rule.ids 315,786,790,1382,27955,27956,46327,46751
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1tb9MwED5Nm9DgAy8dGxmMGQntW7a8Oa7Fp20wOiiVgO5FCMlyHFuqJtJpbSXgE_-Bf7hfsrt4WVvEJMSnJJJj2Ze783Pny2OAl8akQsa6HdrMyTBzNgllmcZhYnU7d7HW3NRsn728c5S9O-WnC_Cq-RfG80PcJNzIMmp_TQZOCemdKWtoMSD6Z_K_S2jtnKzy9acpd5Ro-41KCplTLpOGeTZKdpo359aiJRLrd6qN1CMUj_PnWvwNeM7j2HohOngAX5sp-PqTs-3JuNg2P_9gd_zPOT6E-9cAle16jXoEC7ZqwcpuhcH5tx9si9Ulo3UuvgV39pq75f3m4LgW3JvhOFyB4xM7ZrgCXEwoL8eGjjkc0rAiR1td_vpNT4NqiHrMDP3GNWIIo9nMvjobVGxcqwez044fw9HBm_5-J7w-zCE0hBFQFzLjMHxKEoEYVEeFTbkthaGcsUSYJTMMXDKRmNJySyxcpTO4kNrIpYXhGEqvwmKFg3sCzJTCFpFsG4khNS-dzjJsXcY5cRkWcRTAi-azqnPP2aE8O3OiUKCKBBrAVv29bxroizOqcRNcnfTequO88yXvys_qYwAbcwox0yMi4TwOYLNREIVypu0WXdnhZKTQWdKmZHR7CyHofNI4C2DNa9a0c4QNqYxpmLV-3DoPtXfYp-v6vzbchOVO_0NXdQ9775_CXV9Sx9FZPoNFVAW7gRhrXDyvbekKrhUiwg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD5Cm7jsgUu3sQBjRkJ7y5Y4TlI_7kLpYKq47CZ4sBLHlqpp6bS20uCJ_8A_5Jdwjt2sLWIS4imJ5Fj2yefj79gnnwFea53kMi7aoRFWhsIaHsoqiUNuinZm46JItVP77GXdY_HuLD2bZFXSvzBeH-JmwY1GhvPXNMAvK7s9FQ0t-6T-TO53UWQJp8Br_9NUOipv-31KipiTVPJGeDbi282bc1PRIln1mlIjiyFax_pjLf7GO-dprJuHOo_ga9MDn35yvjUelVv6-x_ijv_XxcfwcEJP2Y7H0xO4Y-oWLO_UGJpffGObzCWMupX4Ftzdbe7u7zXHxrVgaUbhcBlOTs2Iof-_GtOqHBtYZrFFg5rcbP3rx0966tcDRDHT9BPXkCGJZjO76qxfs5EDBzPTilfguPPmaK8bTo5yCDUxBESC0BaDJ85zZKBFVJokNVWuacVYIsmSAsMWkXNdmdSQBldlNU6jJrJJqVMMpFdhocbGrQHTVW7KSLa1xIA6rWwhBJau4oyUDMs4CuBV81XVpVfsUF6bmSs0qCKDBrDpPvdNgeLqnDLc8lSd9t6qk6z7JTuUn9XHANbn8DBTI_LgLA5go8GHQjvTZktRm8F4qNBV0pZkdHuJPKfTSWMRwFMPrGnlSBoSGVMzHTxu7YfaPTii67N_LbgB9z7sd9ThQe_9c3jg8-lS9JQvYAGRYNaRYI3Kl24k_QYz_iFx
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Wet+extrusion+of+fibronectin-fibrinogen+cables+for+application+in+tissue+engineering&rft.jtitle=Biotechnology+and+bioengineering&rft.au=Underwood%2C+S&rft.au=Afoke%2C+A&rft.au=Brown%2C+R+A&rft.au=MacLeod%2C+A+J&rft.date=2001-05-20&rft.issn=0006-3592&rft.volume=73&rft.issue=4&rft.spage=295&rft.epage=305&rft_id=info:doi/10.1002%2Fbit.1062&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-3592&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-3592&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-3592&client=summon